AdRSV‑F
Respiratory Syncytial Virus
PreclinicalActive
Key Facts
About Adimmune
Taiwanese biotech delivering rapid, adjuvant‑enhanced subunit vaccines for emerging infectious diseases.
View full company profileTherapeutic Areas
Other Respiratory Syncytial Virus Drugs
| Drug | Company | Phase |
|---|---|---|
| Vaxine RSV Vaccine | Vaxine | Phase 1 |
| RSV Vaccine | Artificial Cell Technologies | Pre-clinical |
| MDL-001 | Model Medicines | Preclinical |
| MNM‑siRNA RSV | Interna TX | Preclinical |